Searching...Lobbying Arrangements: Pharmacy
New Lobbying Registrations About Pharmacy By Quarter
Former Covered Federal Workers:
Other Lobbyists:
| Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
|---|---|---|---|---|---|
| Details general health care, medical care and pharmaceutical issues |
Pharmaceutical Research and Manufacturers of America (PhRMA)
trade association acting on behalf of brand name drug manufacturers |
Breaux Lott Leadership Group | |||
| Details The Affordable Care Act, provisions relating to essential health benefits and patient protections. Medicare Part B provisions relating to home infusion of IVIG, particularly in CIPD and H.R. 3808. ... |
PLASMA PROTEIN THERAPEUTICS ASSOCIATION
|
in-house lobbying | |||
| Details Educate members and staff about Acordas products. Secure funding through the annual appropriation process for research. Educate staff about Acordas products and research interests. |
Acorda Therapeutics, Inc.
|
Fabiani & Company | |||
| Details Trade Association for certain Pharmaceutical Companies |
Pharmaceutical Research and Manufactures of America
|
Mr. Theodore (Ted) Jones | |||
| Details Seeking U.S. Embassy support for American sales of pharmaceuticals in Latin America |
Schering Corporation
Pharmaceutical research and products |
TEW CARDENAS, LLP | |||
| Details TRICARE |
Sanofi-Aventis
|
Hamilton Advisors | |||
| Details Developing support for issues that impact the development of new pharmacuetical products |
Pharmaceutical Research and Manufacturers of America
|
WATTS PARTNERS | |||
| Details Medicare and Medicaid |
Carolinas HealthCare System
|
Mr. James G. Martin | |||
| Details Public Law 115-271-SUPPORT for Patients and Communities Act; S.469-The Affordable and Safe Prescription Drug Importation Act; Public Law 114-145-The Ensuring Patient Access and Effective Drug Enfor... |
Healthcare Distribution Alliance f/k/a Healthcare Distribution Management Assoc.
|
Brown Rudnick LLP | |||
| Details Issues related to safety of breast cancer drugs |
Abraxis BioScience LLC
|
WINSTON & STRAWN LLP | |||
| Details Represent the client on issues related to assuring a safe, reliable supply of heparin and also on patent matters, including settlements and extensions. |
Fresenius Kabi USA (formerly known as APP Pharmaceuticals, Inc.)
|
WINSTON & STRAWN LLP | |||
| Details Bringing awareness of the pharmaceutical authentication product to Committees of Congress and federal agencies; Seek to include an authentication provision in legislation addressing counterfeit dru... |
XStream Systems, Inc.
|
ALCALDE & FAY | |||
| Details Bringing awareness of the pharmaceutical authentication product to Committees of Congress and federal agencies; Seek to include an authentication provision in legislation addressing counterfeit dru... |
Alcalde & Fay (XStream Systems, Inc.)
|
CML Consulting Services Inc. (formerly L.A. Skip Bafalis) | |||
| Details Monitor status of pharmaceutical pricing inquiry. |
Lundbeck, Inc. (Formerly Ovation Pharmaceuticals, Inc.)
|
Peck, Madigan, Jones & Stewart, Inc. | |||
| Details Implementation of The American Recovery and Reinvestment Act of 2009, Provisions relating to Health Information Technology HR 3962 Affordable Health Care for America Act: provisions pertaining to p... |
NovoLogix (formerly Ancillary Care Management)
|
US STRATEGIES | |||
| Details FY 2018 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (HR 3358, S 1771) Health Care Issues; FY 2018 Departments of Labor, Health and Human ... |
340b Health (FKA Safety Net Hospitals for Pharmaceutical Access)
|
McAllister & Quinn, LLC | |||
| Details HR 6 "The 21st Century Cures Act," all provisions pertaining to patient access to treatments and orphan drug incentives. Senate draft legislation currently titled "Innovation for Healthier America... |
XOMA Corporation (FKA XOMA (US) LLC)
|
in-house lobbying | |||
| Details Health Care Reform and Implementation |
Healthcare Leadership Council
|
TPM Communications | |||
| Details Food and Drug Administration policy. |
ORCHID CHEMICALS & PHARMACEUTICALS LTD.
|
LATHAM & WATKINS LLP | |||
| Details - Issues related to OTC drug products. - Issues related to pseudoephedrine and acetaminophen. - Issues related to the regulation of cosmetic products. - H.R. 1078, Food and Drug Administration Sa... |
McNeil Consumer Healthcare LLC
Consumer healthcare products |
FOLEY HOAG LLP | |||
| Details H.R. 2770 - To ensure prompt payment for drugs and biologicals under Part B of the medicare program. |
AmerisourceBergen
|
Alexander J. Beckles, L.L.C | |||
| Details S.___ Affordable Healthy Futures Act; Americas Affordable Health Choices Act H.R.3200. The Patient-Centered Outcomes Research Act, S.1213; Comparative effectiveness research H.R.2505; Implementatio... |
GlaxoSmithKline
pharmaceutical company |
FOLEY HOAG LLP | |||
| Details S. 3574, Common Sense Nutrition Disclosure Act of 2012, issues relating to food labeling Issues relating to retirement and pensions, including multi-employer pension plans |
SUPERVALU INC.
|
in-house lobbying | |||
| Details S. 3574, Common Sense Nutrition Disclosure Act of 2012, issues relating to food labeling Issues relating to retirement and pensions, including multi-employer pension plans |
SUPERVALU INC.
|
in-house lobbying | |||
| Details The 340B Drug Pricing Program; The Protect 340B Act; FY24 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations bill. HR 3290,to amend title III of th... |
340B Health
|
in-house lobbying | |||
| Details care and treatment of diabetes |
Novo Nordisk, Inc.
|
Ms. Laura Lawlor | |||
| Details Authorization, Appropriations, Security Classification Procedures, and Research and Development policy for pharmacuetical packaging, directed energy materials, armor, laser communications, volumetr... |
SCHOTT North America, Inc.
|
in-house lobbying | |||
| Details Lobby congress to pass HR 6641 - DMEPOS Relief Act of 2022 Maintain competitive bidding methodology (CBP) reforms to protect access to home respiratory therapy. Decrease Medicare documentation in... |
Apria Healthcare LLC
|
in-house lobbying | |||
| Details Monitor biologics related issues, Medicare Part D |
Eli Lilly and Co
|
RASKY BAERLEIN STRATEGIC COMMUNICATIONS | |||
| Details - Issues related to OTC drug products. - Issues related to pseudoephedrine and acetaminophen. - Issues related to the regulation of cosmetic products. - H.R. 1078, Food and Drug Administration Sa... |
McNeil Consumer Healthcare LLC
Consumer healthcare products |
FOLEY HOAG LLP |